Real-World Evidence Sheds Light on SYMPAZAN® Oral Film Use for Lennox-Gastaut Syndrome

Assertio Holdings has announced the results of the first real-world evidence study evaluating patient experience with SYMPAZAN® (clobazam) oral film, presented at the 150th Annual Meeting of the American Neurological…

Continue Reading Real-World Evidence Sheds Light on SYMPAZAN® Oral Film Use for Lennox-Gastaut Syndrome

Dewpoint Therapeutics Secures Series D Funding to Pioneer Novel Gastric Cancer Therapy

Dewpoint Therapeutics, a U.S.-based biotechnology innovator, has announced the successful closure of its Series D financing round. As reported by thepharmaletter, Dewpoint Therapeutics is renowned for its pioneering work in…

Continue Reading Dewpoint Therapeutics Secures Series D Funding to Pioneer Novel Gastric Cancer Therapy

Breaking Ground: Palvella Therapeutics Completes Enrollment in Phase 2 TOIVA Trial for QTORIN™ Rapamycin in Cutaneous Venous Malformations

Palvella Therapeutics, Inc. has announced a key milestone in the development of therapies for rare genetic skin diseases: the completion of enrollment in its Phase 2 TOIVA trial of QTORIN™…

Continue Reading Breaking Ground: Palvella Therapeutics Completes Enrollment in Phase 2 TOIVA Trial for QTORIN™ Rapamycin in Cutaneous Venous Malformations